Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Leirong Wang
Institutions:
Shandong Tumor Hospital,
Shandong First Medical University
Observed institutions:
Shandong University,
Shandong Tumor Hospital,
Affiliated Hospital of Qingdao University,
Shandong First Medical University
ORCID:
0000-0002-3593-2209
Observed ORCID:
0000-0002-3593-2209
OpenAlex ID:
A5058760639
Role of long non‐coding RNA in drug resistance in non‐small cell lung cancer
2018
·
Leirong Wang
, Leina Ma
, et al.
·
Thoracic Cancer
·
65
PDF
N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization
2021
·
Jiandong Liu
, Dongyang Wang
, et al.
·
Archives of Toxicology
·
35
Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small‐cell lung cancer patients treated with first‐line platinum‐containing chemotherapy
2021
·
Man He
, Xiaorui Chi
, et al.
·
Thoracic Cancer
·
30
Tumor-derived Immunoglobulin-like transcript 4 facilitates angiogenesis of colorectal cancer.
2023
·
Jing Liu
, Fang Zhang
, et al.
·
PubMed Central
·
14
PDF
Blood cell parameters as prognostic predictors of disease development for patients with advanced non‑small cell lung cancer
2020
·
Leirong Wang
, Hongzong Si
, et al.
·
Oncology Letters
·
13
PDF
ILT4 facilitates angiogenesis in non‐small cell lung cancer
2024
·
Shuyun Wang
, Jing Wang
, et al.
·
Cancer Science
·
5
Impact of irae characteristics on efficacy of consolidative immunotherapy following chemoradiotherapy in locally advanced NSCLC
2025
·
Xiufen Wang
, Xuebing Fu
, et al.
·
BMC Pulmonary Medicine
·
4
PDF
Tumor-derived immunoglobulin-like transcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherapy in lung adenocarcinoma
2025
·
Leirong Wang
, Qing Li
, et al.
·
Translational Oncology
·
4
Prognostic value of body mass index for first-line chemoimmunotherapy combinations in advanced non-small cell lung cancer in Chinese population
2024
·
Yanxin Sun
, Qi Dang
, et al.
·
Heliyon
·
3
PDF
Impact of ILT4 on lipid metabolism of tumor-associated macrophages to drive immunosuppression and tumor progression in NSCLC.
2026
·
Shuyun Wang
, Yihui Ge
, et al.
·
Journal of Clinical Oncology
Optimization of First‐Line Treatment Options in HER2 ‐Altered Lung Adenocarcinoma: A Real‐World Study
2025
·
Xiufen Wang
, Dahai Wang
, et al.
·
Cancer Medicine
PDF
Tumor-derived ILT5 and suppression of T cell immunity in non-small cell lung cancer.
2025
·
Xuebing Fu
, Huijun Xu
, et al.
·
Journal of Clinical Oncology
PDF
Prognostic impact of the timing of immunotherapy in first‐line immunochemotherapy for patients with advanced lung adenocarcinoma: A propensity score‐matched analysis
2025
·
Yanxin Sun
, Zhenzhen Deng
, et al.
·
International Journal of Cancer
Tumor-derived ILT3 inhibition to reshape the immunosuppressive microenvironment and potentiate the PD-L1 blockade immunotherapy in lung adenocarcinoma.
2024
·
Leirong Wang
, Yanxin Sun
, et al.
·
Journal of Clinical Oncology
Impact of timing of immunotherapy in survival among patients with advanced lung adenocarcinoma treated with first-line immunochemotherapy: A propensity score matching.
2024
·
Yanxin Sun
, Leirong Wang
, et al.
·
Journal of Clinical Oncology
PDF
Response to first-line therapies in metastatic lung adenocarcinoma with low PD-L1 expression: A multi-center retrospective study.
2024
·
Yihui Ge
, Aiqin Gao
, et al.
·
Journal of Clinical Oncology
Efficacy of first‐line treatment options beyond RET‐TKIs in advanced RET‐rearranged non‐small cell lung cancer: A multi‐center real‐world study
2024
·
Yihui Ge
, Juan Li
, et al.
·
Cancer Medicine
PDF
Show more works
View as search
Works count:
17
Citation count:
173
H-index:
5
I10-index:
5
Year
Topic
Type